MedTrace Logo

Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children

NCT02381028 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2015-03-06

No results posted yet for this study

Summary

The aim of this small pilot study is to assess the potential effects and risks of applying fresh human milk locally on eczema spots in children with atopic eczema. This is a split body, controlled, randomized and physician blinded pilot study, of children with atopic eczema with two similar contralateral eczema spots having a mother breastfeeding the child or a sibling. Fresh expressed milk and emollient is to be applied on the intervention spot and emollient alone on the control area, three times a day for four weeks. Severity and area of the eczema spots is evaluated weekly, and samples from milk and the spots were analysed weekly with respect to bacterial colonisation.

Conditions

  • Atopic Eczema

Interventions

OTHER

Human milk and emollient: Apobase creme® (Actavis Norway AS)

Topical application of human milk followed by emollient

OTHER

Emollient: Apobase creme® (Actavis Norway AS)

Topical application of emollient

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Teresa L Berents, MD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-11-30
Completion
2010-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02381028 on ClinicalTrials.gov